These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1903061)

  • 1. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.
    McPherson R; Hogue M; Milne RW; Tall AR; Marcel YL
    Arterioscler Thromb; 1991; 11(3):476-81. PubMed ID: 1903061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cholesteryl ester transfer protein in reverse cholesterol transport.
    McPherson R; Marcel Y
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I31-4. PubMed ID: 2044257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
    Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
    Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence.
    Quinet EM; Huerta P; Nancoo D; Tall AR; Marcel YL; McPherson R
    J Lipid Res; 1993 May; 34(5):845-52. PubMed ID: 8509722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution.
    Evans GF; Bensch WR; Apelgren LD; Bailey D; Kauffman RF; Bumol TF; Zuckerman SH
    J Lipid Res; 1994 Sep; 35(9):1634-45. PubMed ID: 7806977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.
    McPherson R; Mann CJ; Tall AR; Hogue M; Martin L; Milne RW; Marcel YL
    Arterioscler Thromb; 1991; 11(4):797-804. PubMed ID: 2065034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol normalizes cholesteryl ester transfer in IDDM.
    Bagdade JD; Stein E; Ritter MC
    Diabetes Care; 1995 Oct; 18(10):1341-6. PubMed ID: 8721935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.
    Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S
    Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.
    Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Rezzonico L; Chiesa G; Sirtori CR
    Arteriosclerosis; 1989; 9(4):462-9. PubMed ID: 2751476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
    Bagdade JD; Kaufman D; Ritter MC; Subbaiah PV
    Atherosclerosis; 1990 Oct; 84(2-3):145-54. PubMed ID: 2282096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency.
    Noto H; Kawamura M; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
    Atherosclerosis; 2003 Nov; 171(1):131-6. PubMed ID: 14642415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
    Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.
    Chiesa G; Michelagnoli S; Cassinotti M; Gianfranceschi G; Werba JP; Pazzucconi F; Sirtori CR; Franceschini G
    Metabolism; 1993 Feb; 42(2):229-35. PubMed ID: 8474321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states.
    Lottenberg AM; Nunes VS; Lottenberg SA; Shimabukuro AF; Carrilho AJ; Malagutti S; Nakandakare ER; McPherson R; Quintão EC
    Atherosclerosis; 1996 Oct; 126(2):265-75. PubMed ID: 8902152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
    Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
    Contacos C; Barter PJ; Vrga L; Sullivan DR
    Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
    Korhonen T; Hannuksela ML; Seppänen S; Kervinen K; Kesäniemi YA; Savolainen MJ
    Eur J Clin Pharmacol; 1999 Feb; 54(12):903-10. PubMed ID: 10192749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.
    Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA
    Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.